08 Aug founders Posted at 10:41h in by adminaltheia 0 Comments 0 Likes PAOLO FIORINA, MDCO-FOUNDER & SCIENTIFIC ADVISORPAOLO FIORINA, MDCO-FOUNDER & SCIENTIFIC ADVISORPaolo Fiorina, MD, PhD is an endocrinologist. He is Director, International Center for T1D, Romeo ed Enrica Invernizzi Pediatric, University of Milan, Italy; Professor of Endocrinology, L. Sacco Hospital, University of Milan; Chief of Division of Endocrinology, ASST Sacco-Fatebenefratelli, Milan, Italy and Lecturer on Pediatrics, Boston Children’s Hospital, Harvard Medical School. He is actively involved in the Grant Committee of JDRF, Medical Science Review Committee (MSRC) for Islet Biology and Transplantation, Transplant Meeting Committee at the San Raffaele Hospital (Milan), American Heart Association (AHA), and American Society of Transplantation (AST).He published over 140 peer-reviewed manuscripts (5700+ citations, h-index 44). He is focused in devising new immune-based preventive and therapeutic strategies for autoimmune diseases.His publication track record includes seminal contribution to the field of immunotherapy for the treatment of type 1 diabetes and of transplantation and stem cells to prevent and treat autoimmune diabetes and allograft rejection.AurorA-TTTECHNOLOGY TRANSFER COMPANYAurorA-TTTECHNOLOGY TRANSFER COMPANYAurorA-TT is a Technology Transfer Intermediation Company established in 2017 based in Milan, Italy. We identify promising scientific breakthroughs from academia and research centers in Italy and partner with academia, research institutions and biotech companies based globally.We do invest in pre-seed and seed projects to bridge the gap between basic research and industrial drug development with industrial discipline. Successful projects either become assets for the creation of stand-alone companies, partnership with financial investors, biotech and pharma companies, or translate into agreements of varying nature with synergic partners.aurora-tt.comALESSANDRA BIFFI, MDCO-FOUNDER, BOARD MEMBER & SCIENTIFIC ADVISORALESSANDRA BIFFI, MDCO-FOUNDER, BOARD MEMBER & SCIENTIFIC ADVISORAlessandra Biffi, MD, is a pediatric hematologist and stem cell transplant physician. She is Professor of Pediatrics, University of Padua and Chief of the Pediatric Onco-hematology Unit of Padua Hospital; until September 2018, Director of the Gene Therapy Program, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Principal Scientist at the Harvard Stem Cell Institute, Chair of the Scientific Review Committee for Gene Therapy at Boston Children’s Hospital, and Associate Professor of Pediatrics Harvard Medical School.She published over 60 peer-reviewed manuscripts and textbook chapters. She is actively involved in gene therapy trials for neurological genetic diseases, hemoglobinopathies and immunodeficiencies and has developed a unique expertise in the pre-clinical development and clinical testing of hematopoietic stem cell gene therapy approaches.Her publication track record includes seminal contribution to the field of cell and gene therapy.